Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07033260

Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension

The Predictive Value of Carotid Corrected Flow Time and Peak Flow Velocity Variability for Intradialytic Hypotension: A Prospective Multicenter Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
183 (estimated)
Sponsor
First Affiliated Hospital of Wannan Medical College · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

This multicenter, prospective observational study aims to evaluate the predictive value of carotid corrected flow time (FTc) and peak flow velocity variability (PFVV) for hypotension during maintenance hemodialysis. Conducted at The First Affiliated Hospital of Wannan Medical College, Wuhu City Second People's Hospital, Wuhu Hospital of Chinese Traditional Medicine, Wuhu Jinghu District Hospital, and Wuhu Guangji Hospital, the study will include adult patients (≥18 years) with end-stage renal disease (ESRD) on long-term hemodialysis for at least three months. Patients with acute kidney injury, severe cardiac conditions, or other factors affecting results will be excluded. Ultrasound assessments of FTc and PFVV will be performed once, at 1 hour after dialysis initiation. Blood pressure will be monitored during the procedure. The primary outcome is to determine the sensitivity, specificity, and optimal cutoff points of FTc and PFVV in predicting intradialytic hypotension. The estimated sample size is 183 participants, with analysis performed using ROC curves and multivariate regression. The protocol complies with ethical standards and aims to develop a simple, non-invasive, real-time tool to improve patient safety and individualized management during hemodialysis.

Conditions

Interventions

TypeNameDescription
OTHERNon-invasive MonitoringAll participants will undergo non-invasive ultrasonographic measurement of carotid corrected flow time (FTc) and peak flow velocity variability (PFVV) before and during hemodialysis sessions. No treatment or experimental intervention will be applied.

Timeline

Start date
2025-02-01
Primary completion
2025-08-30
Completion
2025-08-30
First posted
2025-06-24
Last updated
2025-06-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07033260. Inclusion in this directory is not an endorsement.